BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3839126)

  • 1. Effect of the dialdehyde derivative of 5'-deoxyinosine on pyrimidine deoxyribonucleoside metabolism in L1210 cells.
    Ohmstede CA; Cory JG
    Biochem Pharmacol; 1985 May; 34(10):1717-24. PubMed ID: 3839126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid determination of thymidylate synthase activity and its inhibition in intact L1210 leukemia cells in vitro.
    Yalowich JC; Kalman TI
    Biochem Pharmacol; 1985 Jul; 34(13):2319-24. PubMed ID: 3160352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased thymidylate synthase in L1210 cells possessing acquired resistance to N10-propargyl-5,8-dideazafolic acid (CB3717): development, characterization, and cross-resistance studies.
    Jackman AL; Alison DL; Calvert AH; Harrap KR
    Cancer Res; 1986 Jun; 46(6):2810-5. PubMed ID: 2938731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor cell and antimetabolic effects of 5-ethyl-2'-deoxyuridine and 5'-substituted 5-ethyl-2'-deoxyuridine derivatives.
    Balzarini J; De Clercq E; Kiefer G; Keppeler K; Buchele A
    Invest New Drugs; 1984; 2(1):35-47. PubMed ID: 6469497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies for the measurement of the inhibitory effects of thymidine analogs on the activity of thymidylate synthase in intact murine leukemia L1210 cells.
    Balzarini J; De Clercq E
    Biochim Biophys Acta; 1984 Feb; 785(1-2):36-45. PubMed ID: 6696920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mechanism of action of 3-deazauridine in tumor cells sensitive and resistant to arabinosylcytosine.
    Brockman RW; Shaddix SC; Williams M; Nelson JA; Rose LM; Schabel FM
    Ann N Y Acad Sci; 1975 Aug; 255():501-21. PubMed ID: 171997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of ribonucleotide reductase activity and nucleic acid synthesis in tumor cells by the dialdehyde derivatives of inosine (NSC 118994) and inosinic acid.
    Cory JG; Mansell MM; Whitford TW
    Cancer Res; 1976 Sep; 36(9 pt.1):3166-70. PubMed ID: 987850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of thymidylate synthetase in the cytostatic activity of pyrimidine nucleoside analogues.
    Balzarini J
    Bull Mem Acad R Med Belg; 1985; 140(11):432-40. PubMed ID: 3841831
    [No Abstract]   [Full Text] [Related]  

  • 9. ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study.
    Jackman AL; Taylor GA; Gibson W; Kimbell R; Brown M; Calvert AH; Judson IR; Hughes LR
    Cancer Res; 1991 Oct; 51(20):5579-86. PubMed ID: 1913676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxicity of 5-fluoro-5'-O-nitro-2'-deoxyuridine, a new fluorinated pyrimidine derivative, in L1210 cultures.
    Roberts D; Franklin P; Odom G; Peck C; Chwang TL
    Mol Pharmacol; 1982 Nov; 22(3):760-5. PubMed ID: 6218391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of action of inosine dialdehyde (NSC 118994) in the inhibition of proliferation of tumor cells in culture.
    Plagemann PG; Graff JC; Behrens M
    Cancer Res; 1977 Jul; 37(7 Pt 1):2188-95. PubMed ID: 193637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2'-Deoxy-2'-methylene derivatives of adenosine, guanosine, tubercidin, cytidine and uridine as inhibitors of L1210 cell growth in culture.
    Cory AH; Samano V; Robins MJ; Cory JG
    Biochem Pharmacol; 1994 Jan; 47(2):365-71. PubMed ID: 8304981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of deoxynucleotide metabolism by the deoxycytidylate deaminase inhibitor 3,4,5,6-tetrahydrodeoxyuridine.
    Heinemann V; Plunkett W
    Biochem Pharmacol; 1989 Nov; 38(22):4115-21. PubMed ID: 2688654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of 5-fluorodeoxycytidine and tetrahydrouridine to exploit high levels of deoxycytidylate deaminase in tumors to achieve DNA- and target-directed therapies.
    Mekras JA; Boothman DA; Perez LM; Greer S
    Cancer Res; 1984 Jun; 44(6):2551-60. PubMed ID: 6539164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential affinities of pyrimidine nucleoside analogues for deoxythymidine and deoxycytidine kinase determine their incorporation into murine leukemia L1210 cells.
    Balzarini J; De Clercq E
    Acta Biochim Pol; 1987; 34(2):63-77. PubMed ID: 2823514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of cytidine dialdehyde and its effects on nucleotide and nucleic acid synthesis.
    Kinahan JJ; Pavelic ZP; Leonard RJ; Bloch A; Grindey GB
    Cancer Res; 1980 Mar; 40(3):598-603. PubMed ID: 7471080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymidylate synthetase as target enzyme for the inhibitory activity of 5-substituted 2'-deoxyuridines on mouse leukemia L1210 cell growth.
    De Clercq E; Balzarini J; Torrence PF; Mertes MP; Schmidt CL; Shugar D; Barr PJ; Jones AS; Verhelst G; Walker RT
    Mol Pharmacol; 1981 Mar; 19(2):321-30. PubMed ID: 7231392
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulation of pyrimidine deoxyribonucleotide metabolism by substrate cycles in dCMP deaminase-deficient V79 hamster cells.
    Bianchi V; Pontis E; Reichard P
    Mol Cell Biol; 1987 Dec; 7(12):4218-24. PubMed ID: 3437888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies directed toward testing the "channeling" hypothesis--ribonucleotides----DNA in leukemia L1210 cells.
    Chiba P; Bacon PE; Cory JG
    Biochem Biophys Res Commun; 1984 Sep; 123(2):656-62. PubMed ID: 6435617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporation of two deoxycytidine oxidation products into cellular DNA.
    Wagner JR; Tremblay S; Gowans B; Hunting DJ
    Biochem Cell Biol; 1997; 75(4):377-81. PubMed ID: 9493960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.